Holen Sie sich die Stockscreener-App
0.9446
1.26%
-0.0322
Schlusskurs vom Vortag:
$0.9768
Offen:
$0.98
24-Stunden-Volumen:
16,128
Relative Volume:
0.17
Marktkapitalisierung:
$3.35M
Einnahmen:
$1.31M
Nettoeinkommen (Verlust:
$-7.56M
KGV:
-0.0918
EPS:
-10.2926
Netto-Cashflow:
$-8.25M
1W Leistung:
+1.58%
1M Leistung:
-13.88%
6M Leistung:
-50.03%
1J Leistung:
-83.02%
1-Tages-Spanne:
$0.93
$0.98
1-Wochen-Bereich:
$0.8967
$1.04
52-Wochen-Spanne:
$0.8967
$8.62
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Firmenname
60 Degrees Pharmaceuticals Inc
Sektor
Branche
Telefon
202-327-5422
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
0.9534 | 3.44M | 1.31M | -7.56M | -8.25M | -10.29 |
VRTX
Vertex Pharmaceuticals Inc
|
522.74 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
804.43 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,005.05 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.68 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.07 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
60 Degrees Pharmaceuticals Flags Cash Runway Only Into Early October - Minichart
60 Degrees Pharmaceuticals Updates Strategy for Tick-Borne Diseases - TipRanks
60 Degrees Pharmaceuticals updates investor presentation outlining tafenoquine babesiosis sNDA path, Q2 results and July financing - TradingView
60 Degrees Pharma flags going-concern risk - Stock Titan
60 Degrees Pharmaceuticals to Present at H.C. Wainwright 28th Annual Global Investment Conference - Quiver Quantitative
A pharmaceutical company will post a public presentation Sept. 11. Its management will meet investors in New York. - Stock Titan
60 DEGREES PHARMACEUTICALS, INC. SEC Filing (Aug 26, 2026) - Stock Titan
Degrees (SXTP) Snapshot: Closes with Little Net Change at $1.13 at the Close; Next Test: Price Remains Between $1.07 Support and $1.19 Resistance in the Current UpdateSentiment Divergence - vinanet.vn
Degrees (SXTP) Quarter in Focus: The Bottom-Line Figure Trails Its Comparison under the Current Snapshot; The Stock Finishes Near Unchanged in the Latest ReadingShare Dilution Risk - vinanet.vn
Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail
H.C. Wainwright Maintains 60 Degrees Pharmaceuticals(SXTP.US) With Hold Rating - Moomoo
SXTP Q1 2026 Earnings: Widened Loss of -$1.28 Per Share Misses Estimates as Stock Declines 5.77%Margin Improvement Report - vinanet.vn
60 Degrees Pharmaceuticals (SXTP) Edges Higher, Holding Above $1.14 SupportOption Breadth - Vinanet
SXTP Q1 2026 Earnings: EPS Miss of 65.12% Exposes Pre-Revenue Pipeline Cost PressuresGross Profit Margin - vinanet.vn
60 Degrees Pharmaceuticals (NASDAQ: SXTP) files to register 1.77M resale shares from warrant deal - Stock Titan
60 Degrees Q2 revenue jumps 106% to $208K; loss widens - scanx.trade
ARAKODA maker reports about $2.4M Q2 loss with about $208K revenue - Stock Titan
60 Degrees Pharmaceuticals (SXTP) flags going concern risk as losses deepen - Stock Titan
60 Degrees Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
60 Degrees Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTPW - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Stock News Today - TradingKey
60 Degrees Pharmaceuticals Shareholders Approve Key Governance Actions - The Globe and Mail
60 Degrees Pharmaceuticals Inc (SXTP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
60 Degrees Pharmaceuticals (NASDAQ: SXTP) reports 2026 shareholder vote outcomes - Stock Titan
Lind Global Fund III (SXTP) discloses 5.45% stake with warrant conversion cap - Stock Titan
60 Degrees Pharmaceuticals Completes Private Placement to Raise Capital - TipRanks
60 Degrees Pharmaceuticals Raises $1.0 Million in Private Placement of Stock and Warrants - tradingview.com
60 Degrees Pharmaceuticals (NASDAQ: SXTP) raises $1M in warrant-backed private placement - Stock Titan
60 Degrees Pharmaceuticals issues Series A, Series B warrants exercisable at $1.49 in $1 million private placement - Bitget
SXTP Q1 2026 Earnings: Wider-Than-Expected Loss of $1.28 Per Share Sends Stock Down 16.11%Peak Earnings Alert - vinanet.vn
60 Degrees Pharmaceuticals raises $1M in private placement By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
60 Degrees Pharmaceuticals raises $1M in private placement - Investing.com
60 Degrees Pharmaceuticals Announces Minimum Enrollment - GlobeNewswire
60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026 - Barchart.com
60 Degrees Pharmaceuticals Inc (SXTP) Balance Sheet - TradingKey
60 Degrees Pharmaceuticals Secures US Patent for Tafenoquine Lung Infection Treatment - scanx.trade
60 Degrees Pharmaceuticals Inc - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SXTP|60 Degrees Pharmaceuticals Inc|Price:1.140| - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SXTP Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Revenue Remains UnreportedOne-Time Loss Impact - vinanet.vn
60 Degrees Pharmaceuticals (SXTP) Slips 0.67% as Stock Hovers Near SupportFlat Correction - vinanet.vn
60 Degrees Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTP - TradingView
Enterprise value to revenue forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
60 Degrees Pharmaceuticals (SCTP) Proxy filing Summary - Quartr
60 Degrees Pharmaceuticals (SCTP) Registration Filing Summary - Quartr
60 Degrees Pharmaceuticals (SXTP) Holds Near Support as Selling Pressure EasesCovered Call ETF - vinanet.vn
60 Degrees Pharmaceuticals: FDA-Approved Malaria & Babesiosis Treatments, Clinical Pipeline, and Commercial Growth (2026 Investor Update) – Minichart - Minichart
Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)
Umsatz
Nettogewinn
Free Cashflow
ENV
60 Degrees Pharmaceuticals Inc-Aktie (SXTP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 15 '25 |
Buy |
0.80 |
9,670 |
7,759 |
59,618 |
| DOW GEOFFREY S | President and CEO |
Dec 10 '25 |
Buy |
0.95 |
9,350 |
8,886 |
46,335 |
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
0.63%
3.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):